Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 13/20 | 0.72 |
| ▸ | CCNE1 | P24864 | 12/20 | 0.72 |
| ▸ | CDK5 | Q00535 | 12/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.72 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.72 |
| ▸ | CDK1 | P06493 | 1/20 | 0.72 |
| ▸ | CDK4 | P11802 | 1/20 | 0.72 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.72 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.72 |
| ▸ | CCND1 | P24385 | 1/20 | 0.72 |
| ▸ | CDK7 | P50613 | 1/20 | 0.72 |
| ▸ | CDK9 | P50750 | 1/20 | 0.72 |
| ▸ | CCNH | P51946 | 1/20 | 0.72 |
| ▸ | MNAT1 | P51948 | 1/20 | 0.72 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.72 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.47 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.47 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.47 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5476972 | 0.91 | CDK2 (0.88) | CDK2CCNE1CDK5ALDH1A1SMN1; SMN2 | |
| SCHEMBL5726576 | 0.89 | CDK2 (0.70) | CDK2CCNE1CDK5ALDH1A1SMN1; SMN2 | |
| SCHEMBL5480558 | 0.89 | CDK2 (0.73) | CDK2CCNE1CDK5ALDH1A1SMN1; SMN2 | |
| SCHEMBL5477216 | 0.89 | CDK2 (0.66) | CDK2CCNE1CDK5ALDH1A1SMN1; SMN2 | |
| SCHEMBL5726471 | 0.88 | CDK2 (0.72) | CDK2CCNE1CDK5ALDH1A1SMN1; SMN2 | |
| SCHEMBL5484289 | 0.87 | CDK2 (0.67) | CDK2CCNE1CDK5ALDH1A1SMN1; SMN2 | |
| SCHEMBL5481693 | 0.87 | CDK2 (0.67) | CDK2CCNE1CDK5ALDH1A1SMN1; SMN2 | |
| SCHEMBL5481249 | 0.86 | CDK2 (0.66) | CDK2CCNE1CDK5ALDH1A1SMN1; SMN2 | |
| SCHEMBL7645385 | 0.86 | CDK2 (0.66) | CDK2CCNE1CDK5ALDH1A1SMN1; SMN2 | |
| SCHEMBL5481055 | 0.86 | CDK2 (0.66) | CDK2CCNE1CDK5ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1724270-A2 | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents | Pfizer Italia S.r.l. (IT) | 2006-11-22 | — | — | EP | disclosed |
| EP-1406899-B1 | PHENYLACETAMIDO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS | PFIZER ITALIA SRL (IT) | 2006-11-15 | — | — | EP | disclosed |
| US-20040235919-A1 | Phenylacetamido-thiazole derivatives, process for the preparation and their use as antitumor agents | PFIZER ITALIA S.R.I. (IT) | 2004-11-25 | — | — | US | disclosed |
| EP-1406899-A2 | PHENYLACETAMIDO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS | Pharmacia Italia S.p.A. (IT) | 2004-04-14 | — | — | EP | disclosed |
| WO-2003008365-A2 | PHENYLACETAMIDO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS | PHARMACIA ITALIA S.P.A. (IT) | 2003-01-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235919-A1 | Phenylacetamido-thiazole derivatives, process for the preparation and their use as antitumor agents | CDK2, CDK1, CDKN1A | CDK2 1/4885CCNE1 6/4885CDK5 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.